secwatch.observer — SEC 8-K summary
======================================

Issuer:     GALECTIN THERAPEUTICS INC (GALT)
CIK:        0001133416
Form:       8-K
Filed at:   2026-01-21T23:59:59+00:00
Accession:  0001140361-26-001866
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Galectin Therapeutics approves $450k in retention bonuses for CMO and CFO
-------------------------------------------------------------------------

- Board approves $300,000 cash retention bonus for CMO Dr. Khurram Jamil.
- Board approves $150,000 cash retention bonus for CFO Jack Callicutt.
- Bonuses payable in three equal installments on June 1, Sep 1, Dec 1, 2026.
- Bonuses require repayment if officers voluntarily resign without good reason or are terminated for cause before Dec 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/0001140361-26-001866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/ef20063365_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-001866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer